Published in J Rheumatol on July 09, 1981
Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science (1988) 11.76
Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med (1999) 8.60
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol (1999) 7.59
Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum (1980) 3.87
Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum (1994) 3.52
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
Extensive condyloma lata. Br J Vener Dis (1977) 3.05
Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem (1992) 2.81
Cataract surgery and intraocular lens implantation in patients with uveitis. Ophthalmology (1989) 2.77
Profile of hypertension in elderly subjects. J Assoc Physicians India (2000) 2.59
Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol (1993) 2.56
Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol (2001) 2.55
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant (2006) 2.47
Plasticity of airway cell proliferation and gene expression after acute naphthalene injury. Am J Physiol (1995) 2.45
Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther (1991) 2.44
Sequence analysis of cDNAs for the human and bovine ATP synthase beta subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr Genet (1987) 2.42
Treatment of neurocysticercosis: current status and future research needs. Neurology (2006) 2.41
Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma). Arthritis Rheum (1968) 2.30
cis-acting elements that confer lung epithelial cell expression of the CC10 gene. J Biol Chem (1992) 2.18
Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum (1984) 2.17
Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum (1980) 2.13
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum (2001) 2.11
The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell (1989) 2.07
Earlobe reconstruction using a Limberg flap in six ears. Br J Plast Surg (2003) 2.07
Running and the development of disability with age. Ann Intern Med (1994) 2.05
Diffusion weighted MR imaging of 5-fluorouracil and oxaliplatin-induced leukoencephalopathy. J Postgrad Med (2013) 2.05
Eosinophilic fasciitis. A pathologic study of twenty cases. Am J Pathol (1979) 2.02
Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med (1971) 2.00
The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol (1998) 1.97
Embryonic mouse lung epithelial progenitor cells co-express immunohistochemical markers of diverse mature cell lineages. J Histochem Cytochem (1996) 1.92
D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis. Ann Intern Med (1982) 1.84
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum (2000) 1.82
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum (1999) 1.75
Uncommon presentations of neurocysticercosis. J Neurol Sci (1998) 1.75
Toward less hazardous cigarettes. Current advances. JAMA (1978) 1.74
Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. Arthritis Rheum (1996) 1.73
Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum (1986) 1.72
Drug abuse in Punjab. Br J Addict Alcohol Other Drugs (1979) 1.71
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis (2006) 1.70
Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum (1989) 1.68
Arteriovenous malformation of knee masquerading as juvenile arthritis. Scand J Rheumatol (1998) 1.65
Sciatic nerve division: a cadaver study in the Indian population and review of the literature. Singapore Med J (2010) 1.65
Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abeta1-42/43 expression. Neuron (1998) 1.64
Giant synovial cysts of the calf in patients with rheumatoid arthritis. J Bone Joint Surg Am (1968) 1.62
Subtenons infection by Dirofilaria repens. Indian J Med Microbiol (2006) 1.62
Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG (2006) 1.59
Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med (1977) 1.57
Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum (1979) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma). J Clin Invest (1976) 1.55
Inhibition of hepatic alpha 1-adrenergic effects and binding by phorbol myristate acetate. J Biol Chem (1985) 1.52
Changing pattern of antibiotic sensitivity of Salmonella typhi. Natl Med J India (1999) 1.51
Drugs on a medical campus I. Drug use among medical undergraduates. Drug Alcohol Depend (1979) 1.51
Local recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy. Ann Surg Oncol (1999) 1.50
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med (1994) 1.50
Post-prandial hypertriglyceridemia in patients with type 2 diabetes mellitus with and without macrovascular disease. J Assoc Physicians India (2010) 1.49
Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma). J Lab Clin Med (1978) 1.47
A brief history of the rheumatic diseases. Bull Rheum Dis (1982) 1.46
Interactions between heterologous FtsA and FtsZ proteins at the FtsZ ring. J Bacteriol (1997) 1.45
The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. Ann Intern Med (1967) 1.45
Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine (Baltimore) (1983) 1.44
Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. Arthritis Rheum (1990) 1.43
Leprosy presenting as macrocheilia. Indian J Lepr (2000) 1.43
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum (2001) 1.42
Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum (1985) 1.42
Milk of calcium in the inferior calyx of a hydronephrotic kidney in a tetraplegic patient - a diagnosis to be made before scheduling for extracorporeal shock wave lithotripsy. Spinal Cord (2000) 1.41
Profile of HLA-B27-related 'unclassifiable' seronegative spondyloarthropathy in females and its comparison with the profile in males. Br J Rheumatol (1995) 1.41
Uteroglobin/Clara cell 10-kDa family of proteins: nomenclature committee report. Ann N Y Acad Sci (2000) 1.41
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol (1992) 1.41
Amino acid effects on translational repressor 4E-BP1 are mediated primarily by L-leucine in isolated adipocytes. Am J Physiol (1998) 1.40
Photopheresis for scleroderma? No! J Rheumatol (1992) 1.40
Extracting insights from the shape of complex data using topology. Sci Rep (2013) 1.40
The natural history of ankylosing spondylitis: is the disease really changing? J Rheumatol (1989) 1.40
Bilateral acetazolamide-induced choroidal effusion following cataract surgery. Eye (Lond) (2007) 1.40
Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine (Baltimore) (1980) 1.39
Extra corporeal shock wave lithotripsy of calculi located in lower calyx of left kidney in a spinal cord injury patient who has implantation of baclofen pump in the ipsilateral loin. Spinal Cord (2002) 1.39
Botulinum toxin in the treatment of dystonias--a hospital based study. J Assoc Physicians India (2003) 1.39
The laryngeal mask airway and the Guedel airway. Anaesthesia (1994) 1.39
Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK. Br J Cancer (2013) 1.39
Pemphigus herpetiformis. Int J Dermatol (1990) 1.38
Role of botulinum toxin in treatment of achalasia cardia. Indian J Gastroenterol (1996) 1.38
Effect of food, fast and alcohol on serum uric acid and acute attacks of gout. Am J Med (1967) 1.38
Gsh-1: a novel murine homeobox gene expressed in the central nervous system. Dev Dyn (1995) 1.37
The quality of obstetrical clinical practice guidelines promulgated by a specialty society. J Obstet Gynaecol Can (2002) 1.37
Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum (1984) 1.35
Letter: HL-A antigens in progressive systemic sclerosis (scleroderma). Arthritis Rheum (1975) 1.33
Ontogeny of Clara cell-specific protein and its mRNA: their association with neuroepithelial bodies in human fetal lung and in bronchopulmonary dysplasia. J Histochem Cytochem (1996) 1.32
The rheumatic manifestaions of progressive systemic sclerosis (scleroderma). Clin Orthop Relat Res (1968) 1.30
Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature. Arthritis Rheum (1984) 1.30
Distinct genomic copy number in mitochondria of different mammalian organs. J Cell Physiol (1990) 1.30
Conformational mutations in human mitochondrial DNA. Nature (1987) 1.29
Therapeutic keratoplasty in Pseudomonas pyocyaneus corneal ulcers. Br J Ophthalmol (1971) 1.29
The relationships between receptor binding capacity for norepinephrine, angiotensin II, and vasopressin and release of inositol trisphosphate, Ca2+ mobilization, and phosphorylase activation in rat liver. Mol Pharmacol (1985) 1.29
Erythromycin for BCG cold abscess. Lancet (1984) 1.29
Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin". Arthritis Rheum (1991) 1.28
Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations. Arthritis Rheum (1990) 1.27
Tubercular fistula in ano. Br J Surg (1988) 1.27
Tissue-specific expression, hormonal regulation and 5'-flanking gene region of the rat Clara cell 10 kDa protein: comparison to rabbit uteroglobin. Nucleic Acids Res (1990) 1.27